Eosinophilic disorders: Molecular pathogenesis, new classification, and modern therapy
- 14 June 2006
- journal article
- review article
- Published by Elsevier BV in Best Practice & Research Clinical Haematology
- Vol. 19 (3), 535-569
- https://doi.org/10.1016/j.beha.2005.07.013
Abstract
No abstract availableKeywords
This publication has 195 references indexed in Scilit:
- Activation of FIP1L1-PDGFRα requires disruption of the juxtamembrane domain of PDGFRα and is FIP1L1-independentProceedings of the National Academy of Sciences, 2006
- Prevalence, breakpoint distribution, and clinical correlates of t(5;12)Cancer Genetics and Cytogenetics, 2004
- Abnormal Clones of T Cells Producing Interleukin-5 in Idiopathic EosinophiliaNew England Journal of Medicine, 1999
- Hypereosinophilic syndrome in Hodgkin's disease with increased granulocyte-macrophage colony-stimulating factorAnnals of Hematology, 1995
- Response of six patients with idiopathic hypereosinophilic syndrome to interferon alfa*Journal of Allergy and Clinical Immunology, 1994
- Cyclosporin for hypereosinophilic syndromeAnnals of Hematology, 1991
- Acute eosinophilic leukemia with a translocation (10p +; 11q−)Cancer Genetics and Cytogenetics, 1986
- Trisomy 7 and 8 in Ph-negative chronic eosinophilic leukemiaCancer Genetics and Cytogenetics, 1985
- Association of an Inversion of Chromosome 16 with Abnormal Marrow Eosinophils in Acute Myelomonocytic LeukemiaNew England Journal of Medicine, 1983
- Loeffler's endocarditis presenting as mitral and tricuspid stenosisThe American Journal of Cardiology, 1977